10-Q: Evolv Technologies Reports Q3 2026 Results Amidst Control Weaknesses

Evolv Technologies Holdings, Inc. reported Q3 2026 results showing revenue growth but also highlighting material weaknesses in internal controls and ongoing legal settlements.

Summary

• Evolv Technologies Holdings, Inc. reported total revenue of $47.3 million for the third quarter ended September 30, 2026, an increase of 10% compared to $42.9 million in the same period of 2025.
• For the nine months ended September 30, 2026, total revenue was $137.4 million, up 28% from $107.4 million in the prior year.
• The company reported a net loss of $15.6 million for Q3 2026, compared to a net loss of $1.8 million in Q3 2025. For the nine-month period, the net loss was $29.9 million, an improvement from $44.0 million in the prior year.
• As of September 30, 2026, the company had $61.9 million in cash and cash equivalents.
• The company disclosed material weaknesses in its internal control over financial reporting, which have led to restatements of prior financial statements.
• Significant legal proceedings, including a class action lawsuit settlement and derivative lawsuits, have been resolved or are in the process of resolution.
• A settlement in principle with the SEC for a civil monetary penalty of $3.5 million related to alleged violations of reporting, books and records, and internal accounting controls provisions was reached.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a cautiously negative sentiment due to ongoing material weaknesses in internal controls, significant net losses, and substantial legal/regulatory matters, despite revenue growth.

Positives

• Total revenue increased by 10% to $47.3 million for the three months ended September 30, 2026, compared to $42.9 million in the prior year.
• For the nine months ended September 30, 2026, total revenue increased by 28% to $137.4 million.
• Subscription revenue grew by 8% to $24.5 million in Q3 2026 and by 17% to $72.4 million for the nine months ended September 30, 2026.
• Service revenue increased by 22% to $9.5 million in Q3 2026 and by 27% to $27.1 million for the nine months ended September 30, 2026.
• Gross profit margin for subscription revenue improved to 60% in Q3 2026 from 52% in the prior year.
• Annual Recurring Revenue (ARR) was $140.5 million as of September 30, 2026, up 20% year-over-year.
• Remaining Performance Obligation (RPO) was $325.8 million as of September 30, 2026, an increase of 11% from December 31, 2025.
• Adjusted EBITDA improved to $13.1 million for the nine months ended September 30, 2026, from $9.3 million in the prior year.

Negatives

• The company reported a net loss of $15.6 million for Q3 2026, a significant increase from a $1.8 million net loss in Q3 2025.
• For the nine months ended September 30, 2026, the net loss was $29.9 million, although this is an improvement from $44.0 million in the prior year.
• Product revenue gross profit margin decreased to 9% in Q3 2026 from 14% in the prior year.
• License fee and other revenue decreased by 67% to $1.0 million in Q3 2026 due to the expiration of the Distribution and License Agreement.
• General and administrative expenses increased by 48% to $18.7 million in Q3 2026, largely due to non-recurring professional fees and an increase in the SEC settlement accrual.
• The company continues to have material weaknesses in its internal control over financial reporting, impacting its ability to prepare timely and accurate financial statements.
• A $3.5 million settlement with the SEC is pending approval, related to alleged violations of reporting, books and records, and internal accounting controls.

Risks

• Material weaknesses in internal control over financial reporting could lead to future misstatements or failures in timely reporting.
• The company has a history of losses and may not achieve or maintain profitability in the future.
• Operating results may fluctuate due to various factors, including the timing of large customer sales and changes in sales models.
• Supply chain disruptions, including component cost increases, long lead times, and potential tariffs, could adversely affect the business.
• Defects or poor quality in products could lead to rework, replacement costs, and customer dissatisfaction.
• The AI-based weapons detection market is new and evolving, and its growth may not meet expectations.
• The company is subject to ongoing legal proceedings and regulatory investigations, including with the SEC, which could result in significant penalties.
• The company may require additional capital, which might not be available on acceptable terms.

Future Outlook

The company expects to continue to generate losses for the foreseeable future and plans to strategically invest in business areas to support growth. Management expects current cash, cash equivalents, and marketable securities, along with expected cash from operations and borrowing availability, to be sufficient for at least the next twelve months. The company anticipates increased R&D and Sales & Marketing costs for the year ending December 31, 2026, compared to 2025, to support product innovation and go-to-market expansion.

Management Comments

• The company believes its integrated hardware and software platform, delivered through a long-term subscription model, differentiates it from competitors.
• Management views ARR and RPO as key indicators of performance, market acceptance, and customer adoption, reflecting the scale and durability of its Security-as-a-Service model.
• The company is focused on delivering value at the physical threshold of venues and facilities, digitally transforming the visitor experience.
• Management expects continued investment in R&D and sales and marketing to support growth initiatives and SOX remediation efforts.

Industry Context

StockSavvy.ai notes that Evolv Technologies operates in the rapidly evolving AI-powered security screening market, facing increasing demand driven by security concerns but also intense competition and the need for continuous technological advancement. The company's focus on a Security-as-a-Service model with recurring revenue streams aligns with industry trends towards subscription-based solutions.

Comparison to Industry Standards

• Evolv's ARR growth of 20% year-over-year is a positive indicator in the security technology sector, though direct comparisons are difficult without specific competitor data for AI-based screening solutions.
• The company's net loss of $29.9 million for nine months ended September 30, 2026, reflects the high investment phase common in technology sectors focused on rapid growth and market penetration.
• The reported material weaknesses in internal controls are a significant concern and contrast with industry best practices for mature public companies, suggesting a need for substantial remediation.
• The company's focus on subscription revenue (62% of total revenue for nine months ended Sept 30, 2026) aligns with the trend towards recurring revenue models seen across various technology industries.

Corporate Governance

Legal Proceedings

• Class Action Lawsuits: Settled for $15.0 million, with final approval granted on September 24, 2026.
• Derivative Lawsuits: Agreement in principle reached to settle Massachusetts Derivative Action, First Delaware Derivative Action, and Second Delaware Derivative Action. Company agreed to implement corporate governance reforms.
• SEC Investigations: Company has reached a settlement in principle with the SEC Staff to resolve investigations into marketing and sales practices, involving a proposed $3.5 million civil monetary penalty.

Stakeholder Impact

• Shareholders: Potential dilution from future equity financings; volatility in stock price; impact of material weaknesses and legal settlements on company value.
• Employees: Continued investment in R&D and sales/marketing may lead to growth opportunities; potential impact from ongoing restructuring and control remediation efforts.
• Creditors: Company is in compliance with debt covenants as of September 30, 2026, but future performance is key to servicing debt.
• Customers: Continued product development and service improvements are expected; potential impact from any disruptions related to legal or control issues.

Next Steps

• Continue to invest in research and development for product innovation.
• Expand sales and marketing efforts to drive customer acquisition and deployment growth.
• Continue to implement and test controls to remediate material weaknesses in internal control over financial reporting.
• Finalize and implement the SEC settlement, subject to SEC approval.
• Continue to monitor and manage supply chain risks.
• Focus on customer retention and renewal of subscription agreements.

Key Dates

Recommendation

The company shows revenue growth and improving Adjusted EBITDA for the nine-month period, indicating operational progress. However, the persistent material weaknesses in internal controls, significant net losses, and ongoing substantial legal and regulatory matters (including the SEC settlement) present considerable risks that outweigh the positive revenue trends for a strong buy recommendation. A hold recommendation reflects a balanced view of the growth potential against the significant financial and operational risks.

Keywords

security screening, AI, weapons detection, Evolv Express, Evolv eXpedite, subscription revenue, financial reporting, internal controls